GarrabouG, SorianoA, LopezSet al.Reversible inhibition of mitochondrial protein synthesis during linezolid-related hyperlactatemia. Antimicrob Agents Chemother, 2007; 51:962–967.
2.
SorianoA, MiroO, MensaJ. Mitochondrial toxicity associated with linezolid. N Engl J Med, 2005; 353:2305–2306.
3.
De VrieseAS, CosterRV, SmetJet al.Linezolid-induced inhibition of mitochondrial protein synthesis. Clin Infect Dis, 2006; 42:1111–1117.
4.
BresslerAM, ZimmerSM, GilmoreJL, SomaniJ. Peripheral neuropathy associated with prolonged use of linezolid. Lancet Infect Dis, 2004; 4:528–531.
5.
ZivkovicSA, LacomisD. Severe sensory neuropathy associated with long-term linezolid use. Neurology, 2005; 64:926–927.
6.
KuterDJ, TillotsonGS. Hematologic effects of antimicrobials: focus on the oxazolidinone linezolid. Pharmacotherapy, 2001; 21:1010–1013.
7.
MohammedS, KnollS, van Amburg AIII, MennesPA. Cefotetan-induced hemolytic anemia causing severe hypophosphatemia. Am J Hematol, 1994; 46:369–370.
8.
BrautbarN, LeiboviciH, MassrySG. On the mechanism of hypophosphatemia during acute hyperventilation: evidence for increased muscle glycolysis. Miner Electrolyte Metab, 1983; 9:45–50.
9.
ChowMT, LinHJ, MitraEAet al.Hemodialysis-induced hypophosphatemia in a normophosphatemic patient dialyzed for ethylene glycol poisoning: Treatment with phosphorus-enriched hemodialysis. Artif Organs, 1998; 22:905–907.
10.
GeerseDA, BindelsAJ, KuiperMAet al.Treatment of hypophosphatemia in the intensive care unit: a review. Crit Care, 2010; 14:R147.
11.
LiamisG, MilionisHJ, ElisafM. Medication-induced hypophosphatemia: A review. QJM, 2010; 103:449–459.
